The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults

American Journal of Medicine

Volumn 101, Issue 1, 1996, Pages 19-24

  Westphal, Sydney A ^a,b  

^a MARICOPA MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIET THERAPY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030199365     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00076-9     Document Type: Article

References (21)

1. 1. Felig P, Bergman M. The endocrine pancreas: diabetes mellitus. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and Metabolism. 3rd ed. New York:McGraw-Hill;1995:1107-1250.
2. 2. Genuth SM. Clinical remission in diabetes mellitus: studies of insulin secretion. Diabetes. 1970;19:116-121.
3. 3. Alford FP, Martin FIR, Pearson MJ. Improvement in both insulin sensitivity and release following diabetic coma. Diabetes. 1971;20:246-249.
4. 4. Block MB, Mako ME, Steiner DF, Rubenstein AH. Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery. J Clin Endocrinol Meta. 1972;35:402-406.
5. 5. Rendell M, Zarriello J, Ross D. Recovery from decompensated non-insulin-dependent diabetes mellitus: studies of C-peptide secretion. Diabetes Care. 1981;4:354-359.
6. 6. Matsuda A, Kuzuya T. Urine C-peptide after recovery from diabetic ketoacidosis: an index of insulin dependency. Diabetes Care. 1982;5:581-584.
7. 7. Torella R, Salvatore T, Cozzolino D, Grandillo F, Giugliano D. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus. Acta Diabetol Lat. 1988;25:161-173.
8. 8. Banerji MA, Lebovitz HE. Remission in non-insulin-dependent diabetes mellitus: clinical characteristics of remission and relapse in black patients. Medicine. 1990;69:176-185.
9. 9. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 AND DR4. Diabetes. 1994;43:741-745.
10. 10. Melton LJ, Palumbo PJ, Chu CP. Incidence of diabetes mellitus by clinical type. Diabetes Care. 1983;6:75-86.
11. 11. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc. 1992;40:1100-1104.
12. 12. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A. Comparison of childhood and adult type I diabetes mellitus. N Engl J Med. 1989;320:881-886.
13. 13. Genuth S. Management of the adult onset diabetic with sulfonylurea drug failure. Endocrinology and Metabolism Clinics of North America. 1992;21:351-370.
14. 14. Irvine WJ, McCallum CJ, Gray RS, Duncan LJP. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypolgycaemic agents Lancet. 1977;May 14:1025-1027.
15. 15. DiMario U, Irvine WJ, Borsey DQ, Kyner JL, Weston J, Glafo C. Immune abnormabilities in diabetic patients not requiring insulin at diagnosis. Diabetologia. 1983;25:392-395.
16. 16. Gleichmann M, Zörcher B, Greulich B, Gries FA, Henrichs HR, Bertrams J, Kolb H. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia. 1984;27:90-92.
17. 17. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes. 1986;35:237-241.
18. 18. Hother-Neilsen O, Faber O, Sorensen NS, Beck-Neilsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care. 1988;11:531-537.
19. 19. Groop L, Groop PH, Koskimies S. Relationship between β-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:757-760.
20. 20. Morrison EY St A, Ragoobirsingh D, Thompson H, Fletcher C, Smith-Ricardson S, et al. Extensive personal experience: phasic insulin dependent diabetes mellitus: manifestations and cellular mechanisms. J Clin Endocrinol Metab. 1995;80:1996-2001.
21. 21. Johnson DD, Palumbo PJ, Chu CP. Diabetic Ketoacidosis in a community-based population. Mayo Clin Proc. 1980;55;83-88.